Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial

Faster, Cleaner, Better.

GT Biopharma Inc (GTBP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	09-2004	06-2004	03-2004	12-2003	09-2003
Assets
Current Assets
Cash & Cash Equivalents	786	1,115	308	372	238
Receivables	370	198	291	251	265
Inventories	349	318	270	295	354
Other current assets	25	46	67	0	0
TOTAL	$1,650	$1,814	$1,056	$1,057	$1,024

Non-Current Assets
PPE Net	43	42	36	42	37
Intangibles	969	902	876	834	877
Other Non-Current Assets	0	0	0	30	0
TOTAL	$1,012	$944	$912	$906	$914

Total Assets	$2,662	$2,758	$1,968	$1,963	$1,938

Liabilities
Current Liabilities
Short Term Debt	404	261	119	N/A	N/A
Accounts payable and accrued liabilities	536	636	539	609	436
Accrued Expenses	663	781	288	324	368
Other current liabilities	N/A	N/A	N/A	N/A	71
TOTAL	$2,963	$3,038	$1,106	$1,093	$1,035

Non-Current Liabilities
TOTAL	$N/A	$N/A	$N/A	$N/A	$N/A

Total Liabilities	$2,963	$3,038	$1,106	$1,093	$1,035

Shareholders' Equity
Shares Outstanding, K	27,106	26,716	26,627	26,563	26,306
Common Shares	27	27	26	26	26
Retained earnings	-61,333	-61,280	-60,087	-59,494	-59,274
Other shareholders' equity	509	507	508	-27	-181
TOTAL	$-301	$-280	$862	$870	$903

Total Liabilities And Equity	$2,662	$2,758	$1,968	$1,963	$1,938